23.03.2013 Views

White Guide and Orange Guide Formatting Project - Pfizer

White Guide and Orange Guide Formatting Project - Pfizer

White Guide and Orange Guide Formatting Project - Pfizer

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>Orange</strong> <strong>Guide</strong> – Chapter 8: Privacy: Protecting Personal Information<br />

cost-free mechanism (toll-free number or prepaid mail-in form) must also be provided that allows the<br />

consumer to discontinue or “opt-out” of the program at any time.<br />

These guidelines apply to all <strong>Pfizer</strong> personnel, including disease management teams <strong>and</strong> non-br<strong>and</strong>ed<br />

teams. In addition, they also must be communicated to <strong>and</strong> followed by any <strong>Pfizer</strong>-approved vendors<br />

undertaking such activities on behalf of <strong>Pfizer</strong>.<br />

H<strong>and</strong>ling HCP Personal Data<br />

Restricting Access to Personal Information to a “Need to Know” Basis<br />

As a general policy, <strong>Pfizer</strong> restricts access to sensitive information to individuals who “need to know”<br />

the information. In general, most <strong>Pfizer</strong> colleagues, including Sales Colleagues, do not need access to<br />

Personal Information about HCPs for any reason <strong>and</strong> should not request, collect or retain any such<br />

information. This type of information includes, but is not limited to:<br />

Social Security or other government-issued numbers;<br />

Driver’s license numbers;<br />

Health insurance identification numbers;<br />

Credit card, debit card, bank account numbers, or any other financial account identifiers<br />

(with or without associated security numbers);<br />

Employment identification numbers; <strong>and</strong><br />

Biometric data (fingerprints, voiceprints, or retinal scans).<br />

Access to Personal Information <strong>and</strong>, in particular, collection of Personal Information imposes an<br />

obligation to keep that information confidential <strong>and</strong> secure <strong>and</strong> inform Legal when such information is<br />

lost or stolen. Disclosure of certain types of Personal Information, even if accidental, can expose <strong>Pfizer</strong><br />

to legal liability, create a risk of fraud or even identity theft for the information owner, <strong>and</strong> erode<br />

confidence in <strong>Pfizer</strong> <strong>and</strong> its commitment to privacy <strong>and</strong> information security.<br />

146<br />

Rev. 09/12<br />

Page 13 of 18

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!